Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer

被引：0
作者：
Wen Ouyang
Jing Yu
Yan Zhou
Jing Hu
Zhao huang
Junhong Zhang
Conghua Xie
机构：
[1] Zhongnan Hospital of Wuhan University,Department of Radiation and Medical Oncology
[2] Zhongnan Hospital of Wuhan University,Hubei Key Laboratory of Tumor Biological Behaviors
[3] Zhongnan Hospital of Wuhan University,Hubei Clinical Cancer Study Center
来源：
BMC Cancer | / 20卷
关键词：
Non-small cell lung cancer; Epidermal growth factor receptor; Brain metastases; Risk factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Managing Acquired Resistance in EGFR-Mutated Non-Small Cell Lung Cancer
    Forde, Patrick M.
    Ettinger, David S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (08) : 528 - 532
  • [12] Real-world utilization of EGFR TKIs and prognostic factors for survival in EGFR-mutated non-small cell lung cancer patients with brain metastases
    Yu, Xiaoqing
    Sheng, Jiamin
    Pan, Guoqiang
    Fan, Yun
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (05) : 1121 - 1128
  • [13] Features of patients with advanced EGFR-mutated non-small cell lung cancer benefiting from immune checkpoint inhibitors
    Chen, Qian
    Shang, Xiaoling
    Liu, Ni
    Ma, Xinchun
    Han, Wenfei
    Wang, Xiuwen
    Liu, Yanguo
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [14] Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma
    Ma, Xiaoyan
    Zhu, Hui
    Guo, Hongbo
    Han, Anqin
    Wang, Haiyong
    Jing, Wang
    Zhang, Yan
    Kong, Li
    Yu, Jinming
    ONCOTARGET, 2016, 7 (49) : 81906 - 81917
  • [15] Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance
    Fu, Kai
    Xie, Fachao
    Wang, Fang
    Fu, Liwu
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [16] EGFR-mutated non-small lung cancer brain metastases and radiosurgery outcomes with a focus on leptomeningeal disease
    Alzate, Juan Diego
    Mullen, Reed
    Mashiach, Elad
    Bernstein, Kenneth
    Vasconcellos, Fernando De Nigris
    Rotmann, Lauren
    Berger, Assaf
    Qu, Tanxia
    Silverman, Joshua S.
    Golfinos, John G.
    Donahue, Bernadine R.
    Kondziolka, Douglas
    JOURNAL OF NEURO-ONCOLOGY, 2023, 164 (02) : 387 - 396
  • [17] RNA Sequencing to Characterize Pathways in EGFR-mutated Non-Small Cell Lung Cancer
    Yun, N.
    Naqib, A.
    Borgia, J. A.
    Fidler, M. J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S458 - S459
  • [18] EGFR-mutated non-small lung cancer brain metastases and radiosurgery outcomes with a focus on leptomeningeal disease
    Juan Diego Alzate
    Reed Mullen
    Elad Mashiach
    Kenneth Bernstein
    Fernando De Nigris Vasconcellos
    Lauren Rotmann
    Assaf Berger
    Tanxia Qu
    Joshua S. Silverman
    John G. Golfinos
    Bernadine R. Donahue
    Douglas Kondziolka
    Journal of Neuro-Oncology, 2023, 164 (2) : 387 - 396
  • [19] Treatment patterns and survival analysis in patients with unresectable stage III EGFR-mutated non-small cell lung cancer
    Liang, Huan-Wei
    Liu, Yang
    Pan, Xin-Bin
    AGING-US, 2024, 16 (01): : 857 - 871
  • [20] Cost-effectiveness analysis of osimertinib plus chemotherapy for patients with EGFR-mutated advanced non-small cell lung cancer
    Tian, Wentao
    Niu, Lishui
    Zhou, Rongrong
    Wang, Ziqi
    Ning, Jiaoyang
    Lu, Ruoyu
    Shi, Yin
    Tan, Zhaohua
    CANCER MEDICINE, 2024, 13 (16):
12345